Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and FutunaResearch in context

Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and FutunaResearch in context

Summary: Background: Ending Zero-COVID is challenging, particularly when vaccine coverage is low. Considering Wallis and Futuna, a French Zero-COVID territory affected by reluctance to vaccination, low immunity and high levels of comorbidities, we investigate how targeted use of nirmatrelvir/ritona...

Full description

Bibliographic Details
Main Authors: Antoine Brault, Cécile Tran-Kiem, Clément Couteaux, Valérie Olié, Juliette Paireau, Yazdan Yazdanpanah, Jade Ghosn, Guillaume Martin-Blondel, Paolo Bosetti, Simon Cauchemez
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:The Lancet Regional Health. Western Pacific
Subjects:
COVID-19
SARS-CoV-2
Treatment
Antiviral
Nirmatrelvir/ritonavir
Paxlovid
Online Access:http://www.sciencedirect.com/science/article/pii/S2666606522002498

Internet

http://www.sciencedirect.com/science/article/pii/S2666606522002498

Similar Items